Cargando…
Plasminogen activator inhibitor-1 4G/5G polymorphism and dyslipidemia with branch retinal artery occlusion in a young lady
Branch retinal artery occlusion (BRAO) leads obstruction of blood flow in the distribution of the affected vessel giving rise to ischemia and reorganization of the retinal layers. It is a very rare diagnosis and the etiological risk factors of BRAO are not clean in the young population. Various hype...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7852414/ https://www.ncbi.nlm.nih.gov/pubmed/33542605 http://dx.doi.org/10.4103/ojo.OJO_266_2019 |
_version_ | 1783645817311068160 |
---|---|
author | Kurtul, Bengi Ece Elbeyli, Ahmet Ozcan, Sait Coskun |
author_facet | Kurtul, Bengi Ece Elbeyli, Ahmet Ozcan, Sait Coskun |
author_sort | Kurtul, Bengi Ece |
collection | PubMed |
description | Branch retinal artery occlusion (BRAO) leads obstruction of blood flow in the distribution of the affected vessel giving rise to ischemia and reorganization of the retinal layers. It is a very rare diagnosis and the etiological risk factors of BRAO are not clean in the young population. Various hypercoagulable states leading to thrombosis appeared to be more responsible. Here, the authors present an interesting case of a 25-year-old female patient with BRAO accompanying with plasminogen activator inhibitor-1(PAI-1) 4G/5G gene polymorphism and dyslipidemia together, for the first time. There was a history of sudden painless blurred vision in her right eye 3 months ago. Her visual acuity was 20/20 in both eyes at the admittion. Fundus photo, red-free photo, optical coherence tomography images of 3 months ago revealed BRAO in the right eye. Fundus exam and images taken at the 3th month confirmed the recovery of retinal edema. Attenuation of inferotemporal retinal artery still mildly appeared. Applied confrontation fields showed a visual field defect corresponding with affected area. Ophthalmologists are advised to be aware of the importance of PAI-1 4G / 5G gene polymorphism and dyslipidemia conditions besides the other genetic mutations and thrombophilic markers regarding BRAO in young patients. |
format | Online Article Text |
id | pubmed-7852414 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-78524142021-02-03 Plasminogen activator inhibitor-1 4G/5G polymorphism and dyslipidemia with branch retinal artery occlusion in a young lady Kurtul, Bengi Ece Elbeyli, Ahmet Ozcan, Sait Coskun Oman J Ophthalmol Case Report Branch retinal artery occlusion (BRAO) leads obstruction of blood flow in the distribution of the affected vessel giving rise to ischemia and reorganization of the retinal layers. It is a very rare diagnosis and the etiological risk factors of BRAO are not clean in the young population. Various hypercoagulable states leading to thrombosis appeared to be more responsible. Here, the authors present an interesting case of a 25-year-old female patient with BRAO accompanying with plasminogen activator inhibitor-1(PAI-1) 4G/5G gene polymorphism and dyslipidemia together, for the first time. There was a history of sudden painless blurred vision in her right eye 3 months ago. Her visual acuity was 20/20 in both eyes at the admittion. Fundus photo, red-free photo, optical coherence tomography images of 3 months ago revealed BRAO in the right eye. Fundus exam and images taken at the 3th month confirmed the recovery of retinal edema. Attenuation of inferotemporal retinal artery still mildly appeared. Applied confrontation fields showed a visual field defect corresponding with affected area. Ophthalmologists are advised to be aware of the importance of PAI-1 4G / 5G gene polymorphism and dyslipidemia conditions besides the other genetic mutations and thrombophilic markers regarding BRAO in young patients. Wolters Kluwer - Medknow 2020-11-02 /pmc/articles/PMC7852414/ /pubmed/33542605 http://dx.doi.org/10.4103/ojo.OJO_266_2019 Text en Copyright: © 2020 Oman Ophthalmic Society http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Case Report Kurtul, Bengi Ece Elbeyli, Ahmet Ozcan, Sait Coskun Plasminogen activator inhibitor-1 4G/5G polymorphism and dyslipidemia with branch retinal artery occlusion in a young lady |
title | Plasminogen activator inhibitor-1 4G/5G polymorphism and dyslipidemia with branch retinal artery occlusion in a young lady |
title_full | Plasminogen activator inhibitor-1 4G/5G polymorphism and dyslipidemia with branch retinal artery occlusion in a young lady |
title_fullStr | Plasminogen activator inhibitor-1 4G/5G polymorphism and dyslipidemia with branch retinal artery occlusion in a young lady |
title_full_unstemmed | Plasminogen activator inhibitor-1 4G/5G polymorphism and dyslipidemia with branch retinal artery occlusion in a young lady |
title_short | Plasminogen activator inhibitor-1 4G/5G polymorphism and dyslipidemia with branch retinal artery occlusion in a young lady |
title_sort | plasminogen activator inhibitor-1 4g/5g polymorphism and dyslipidemia with branch retinal artery occlusion in a young lady |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7852414/ https://www.ncbi.nlm.nih.gov/pubmed/33542605 http://dx.doi.org/10.4103/ojo.OJO_266_2019 |
work_keys_str_mv | AT kurtulbengiece plasminogenactivatorinhibitor14g5gpolymorphismanddyslipidemiawithbranchretinalarteryocclusioninayounglady AT elbeyliahmet plasminogenactivatorinhibitor14g5gpolymorphismanddyslipidemiawithbranchretinalarteryocclusioninayounglady AT ozcansaitcoskun plasminogenactivatorinhibitor14g5gpolymorphismanddyslipidemiawithbranchretinalarteryocclusioninayounglady |